Vaccine News and Research

Latest Vaccine News and Research

Key populations need to be prioritized for early COVID-19 immunization in Canada

Canada's National Advisory Committee on Immunization (NACI) recommends vaccinating key populations, such as people at risk of severe illness or death, those at risk of transmitting the virus and essential workers, during the initial rollout of a COVID-19 vaccine in Canada.

3 Nov 2020

Adaptive evolution of human coronaviruses may necessitate frequent reformulation of vaccines

Researchers from the Vaccine and Infectious Disease Division at the Fred Hutchinson Cancer Research Center, USA, have revealed that adaptive evolution in the antigenic regions facilitates seasonal coronaviruses to escape the host immune responses and to cause recurrent infections.

3 Nov 2020

Engineers use electric fields to manipulate viruses in microfluidic device

The technique uses microfluidics -- the submillimeter control of fluids within a precise, geometric structure. On what is basically a tricked-out microscope slide, chemical engineers from Michigan Technological University have been able to manipulate viruses in a microfluidic device using electric fields.

3 Nov 2020

Estonian researchers provide clues to control the aggressive nature of SARS-CoV-2

Recent study by Estonian researchers in University of Tartu explains how coronavirus is activated before attacking the cell and what could help to impede that.

2 Nov 2020

Only 56 percent of people intend to have free flu vaccination in the U.K. amid COVID

Now, a team of researchers at Keele University and Public Health England aimed to determine how many residents in the U.K. intend to get flu shots amid the COVID-19 pandemic. The researchers found that 55.8 percent of people intended to have the vaccination.

2 Nov 2020

Innovative hybrid approach increases vaccinations and primary care visits during pandemic

Nemours Children's Health System increased patient immunizations by 4.6% from January - September 2020, compared with the same period in 2019, through an innovative hybrid approach to care using both in-person and telemedicine, according to new data presented today at the Children's Hospital Association's 2020 Annual Leadership Conference.

2 Nov 2020

Study sheds new light on how the immune system remembers viruses

For a person to acquire immunity to a disease, T cells must develop into memory cells after contact with the pathogen.

2 Nov 2020

Study reveals seven “forms of disease” in COVID-19

In a study recently published in the top journal "Allergy", a team of MedUni Vienna scientists led by immunologist Winfried F. Pickl and allergologist Rudolf Valenta (both from the Center for Pathophysiology, Infectiology and Immunology) showed that there are seven "forms of disease" in COVID-19.

2 Nov 2020

Study: COVID-19 lockdowns increase the number of polio cases in Pakistan

A spike in the number of polio cases in Pakistan — the last refuge of the virus in the world along with neighbouring Afghanistan — is being attributed by health experts to disruption in vaccination services caused by lockdowns and restrictions against spread of the COVID-19 pandemic.

2 Nov 2020

Research shows how remdesivir inhibits SARS-CoV-2 replication

In a recent bioRxiv preprint, a research team from Germany, Goran Kokic et al. study the molecular mechanism of remdesivir-induced stalling of RdRp - using synthetic RNA chemistry, biochemistry, and cryo-electron microscopy.

2 Nov 2020

First-of-its-kind synthetic DNA vaccine designed against Powassan virus

Scientists at The Wistar Institute have designed and tested the first-of-its-kind synthetic DNA vaccine against Powassan virus (POWV), targeting portions of the virus envelope protein.

30 Oct 2020

UIC enrolls people into phase 3 monoclonal antibody clinical trial

Researchers at the University of Illinois Chicago are now enrolling people into a phase 3 clinical trial that will test if a monoclonal antibody treatment -- administered as a series of four shots -- will help protect uninfected individuals from acquiring or getting sick from COVID-19 after someone in the household tests positive for COVID-19.

30 Oct 2020

Scientists develop new model of coronavirus diffusion through a community

The coronavirus doesn't spread uniformly through a community.But in the world of disease modeling, many projections take a high-level approach to a geographic area, like a county or state, and forecast based on a general idea that a virus will take root and spread at an equal rate until it reaches its peak of infection.

30 Oct 2020

Study: ICE detention centers experienced repeated outbreaks of vaccine-preventable illnesses

More than a dozen U.S. Immigration and Customs Enforcement (ICE) detention centers experienced large, repeated outbreaks of vaccine-preventable illnesses in the last three years, according to a new study by researchers at UC San Francisco.

30 Oct 2020

Booster dose enhances immunogenicity of ChAdOx1 SARS-CoV-2 vaccine in aged mice

Now, a new study published on the pre-print server bioRxiv* shows that a single dose of the vaccine has induced cellular and humoral immunity in aged or older mice. A second dosage was needed to enhance the vaccine's immune response, showing that a prime-boost strategy may be an essential step to boost immunogenicity in the elderly.

30 Oct 2020

COVID-19 study: Researchers recruit frontline workers to identify asymptomatic individuals

Fifteen hundred frontline workers are being recruited for a yearlong study to find what percentage are positive for the virus that causes COVID-19, what percentage become positive and whether the antibodies they produce protect them from reinfection.

30 Oct 2020

UH and CWRU announce Phase 3 trial of Astrazeneca's investigational COVID-19 vaccine

University Hospitals and Case Western Reserve University announced today that UH Cleveland Medical Center has been selected as a clinical trial site for the Phase 3 global study of an investigational vaccine against SARS-CoV-2, sponsored by AstraZeneca.

29 Oct 2020

Remdesivir received FDA approval for treating COVID-19 patients: Benefits still not proven

The United States has become the epicenter of the world in the ever increasing pandemic of COVID-19. While public health prevention strategies of social distancing, crowd avoidance, masking and frequent hand washing are of proven benefit, effective drug therapies for treatment are sparse.

29 Oct 2020

New method could help increase effectiveness of vaccines against coronavirus

A University at Buffalo-led research team has discovered a technique that could help increase the effectiveness of vaccines against the novel coronavirus, the virus that causes COVID-19.

29 Oct 2020

Majority of people infected with mild-to-moderate COVID 19 mount robust antibody response

The vast majority of individuals infected with mild-to-moderate COVID 19 mount a robust antibody response that is relatively stable for at least five months, according to research conducted at the Icahn School of Medicine at Mount Sinai and published October 28, in the journal Science.

29 Oct 2020

Vaccine News and Research

Latest Vaccine News and Research

Key populations need to be prioritized for early COVID-19 immunization in Canada

Adaptive evolution of human coronaviruses may necessitate frequent reformulation of vaccines

Engineers use electric fields to manipulate viruses in microfluidic device

Estonian researchers provide clues to control the aggressive nature of SARS-CoV-2

Only 56 percent of people intend to have free flu vaccination in the U.K. amid COVID

Innovative hybrid approach increases vaccinations and primary care visits during pandemic

Study sheds new light on how the immune system remembers viruses

Study reveals seven “forms of disease” in COVID-19

Study: COVID-19 lockdowns increase the number of polio cases in Pakistan

Research shows how remdesivir inhibits SARS-CoV-2 replication

First-of-its-kind synthetic DNA vaccine designed against Powassan virus

UIC enrolls people into phase 3 monoclonal antibody clinical trial

Scientists develop new model of coronavirus diffusion through a community

Study: ICE detention centers experienced repeated outbreaks of vaccine-preventable illnesses

Booster dose enhances immunogenicity of ChAdOx1 SARS-CoV-2 vaccine in aged mice

COVID-19 study: Researchers recruit frontline workers to identify asymptomatic individuals

UH and CWRU announce Phase 3 trial of Astrazeneca's investigational COVID-19 vaccine

Remdesivir received FDA approval for treating COVID-19 patients: Benefits still not proven

New method could help increase effectiveness of vaccines against coronavirus

Majority of people infected with mild-to-moderate COVID 19 mount robust antibody response

Event guide: 3rd mRNA Process Development & Manufacturing Europe eBook

How the Vutara VXL simplifies single-molecule imaging

How cohesin mechanics and nanotracker tech are redefining DNA research

Todd Bauman and Chris Povich

Vaccine News and Research

Latest Vaccine News and Research

Event guide: 3rd mRNA Process Development & Manufacturing Europe eBook

How the Vutara VXL simplifies single-molecule imaging

How cohesin mechanics and nanotracker tech are redefining DNA research

Todd Bauman and Chris Povich

Newsletters you may be interested in